NCT05076461

Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children

Comparison of Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children At a Resource Limited Setting

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 300 (actual)
• Sponsor: Tehsil Headquarter Hospital · Other Government
• Sex: All
• Age: 1 Day – 12 Years
• Healthy volunteers: Accepted

Summary

Most of the trials conducted comparing ondansetron and domperidone have been conducted among children aged below 5 or 6 years of age while no study from Pakistan has compared efficacy of these antiemetic agents among children up to 12 years of age. The findings of present study will give valuable evidence about the effectiveness of these antiemetic agents to prevent vomiting among children suffering with acute gastroenteritis at a resource limited setting of South Punjab, Pakistan.

Detailed description

to compare the efficacy of ondansetron versus domperidone for treating vomiting in acute gastroenteritis in children at a resource limited emergency setting of South Punjab, Pakistan.

Conditions

• Vomiting in Infants and/or Children
• Acute Gastroenteritis

Interventions

Type	Name	Description
DRUG	Ondansetron	Ondansetron group received oral suspension of ondansetron as 0.15mg per body weight

Timeline

• Start date: 2020-07-01
• Primary completion: 2021-06-30
• Completion: 2021-06-30
• First posted: 2021-10-13
• Last updated: 2021-10-13

Locations

1 site across 1 country: Pakistan